Dr. Smethurst's appointment, with his vast experience in onc...
Dr. Smethurst's appointment, with his vast experience in oncology therapeutics, is viewed positively for Corbus. His leadership is anticipated to be key in the upcoming US dose escalation study for CRB-701 and the progression of other Corbus assets.
Press Release: Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4644Followers
0Following
10KVisitors
Follow